SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Targeting ALK in Neuroblastoma: From Discovery to Phase 3 and Back to the Lab
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
1 of
1
|
Targeting ALK in neuroblastoma: From discovery to phase 3 and back to the lab
Yael P Mosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
1 of
1
|